Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2018

Pharma News, 2018

Reversing atherosclerosis with one shot
Reversing atherosclerosis with one shot
New research demonstrates that injecting synthetically designed nanofibers in mice helps to break up the arterial plaque that is a hallmark of atherosclerosis.
Jet-lag supplement may combat obesity: Melatonin burns calories and reduces fat storage around the midriff
Jet-lag supplement may combat obesity: Melatonin burns calories and reduces fat storage around the midriff
Jet-lag supplements may combat obesity, new research suggests.
Deadly brain cancer stopped with new compound
Deadly brain cancer stopped with new compound
Glioblastoma, one of the deadliest forms of brain cancer, may have found its nemesis.
Pfizer's biosimilar of anemia treatments gets FDA nod
Pfizer's biosimilar of anemia treatments gets FDA nod
Pfizer Inc’s biosimilar of anemia treatments from Amgen Inc and Johnson & Johnson was approved by U.
WHO gets approval to use Ebola vaccine in Democratic Republic of Congo
WHO gets approval to use Ebola vaccine in Democratic Republic of Congo
GENEVA (Reuters) - The World Health Organization has been given the go-ahead by officials in the Democratic Republic of Congo to import and use an experimental Ebola vaccine in the country, WH...
AstraZeneca's respiratory rivalry with GlaxoSmithKline takes a hit with Fasenra's phase 3 fail
AstraZeneca's respiratory rivalry with GlaxoSmithKline takes a hit with Fasenra's phase 3 fail
AstraZeneca’s ambitions for keeping pace with GlaxoSmithKline in the severe COPD market just took a big hit.
Medigene in for up to $1.5 billion under broader pact with Bluebird Bio
Medigene in for up to $1.5 billion under broader pact with Bluebird Bio
FRANKFURT (Reuters) - German biotech firm Medigene has secured a wider remit under a collaboration with U.
U.S. to consider expanding Medicare drug price negotiation
U.S. to consider expanding Medicare drug price negotiation
WASHINGTON (Reuters) - The Trump administration is considering expanding Medicare’s ability to negotiate the cost of drugs by giving private payers a role in setting the price of medicines a...
WHO calls for trans fats to be eliminated within five years
WHO calls for trans fats to be eliminated within five years
GENEVA (Reuters) - The world could eliminate industrially-produced trans fats by 2023, the World Health Organization said on Monday, unveiling a plan that it said would prevent 500,000 deaths ...
Teva Canada Announces the Launch of Teva-Cyclosporine Ophthalmic Emulsion, the First Generic Version of Restasis in Canada for the Treatment of Dry Eye Disease
Teva Canada Announces the Launch of Teva-Cyclosporine Ophthalmic Emulsion, the First Generic Version of Restasis in Canada for the Treatment of Dry Eye Disease
TORONTO, May 10, 2018 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd.
Sanofi’s shift to robots and ‘digital twins’ at U.S. biologics site costs 95 jobs
Sanofi’s shift to robots and ‘digital twins’ at U.S. biologics site costs 95 jobs
Sanofi is investing more than $300 million in its Framingham, Massachusetts, plant as it continues a global manufacturing transformation that at some plants leans heavily on robots and digital process...
Janssen Announces DARZALEX® (daratumumab) U.S. FDA Approval for Newly Diagnosed Patients with Multiple Myeloma who are Transplant Ineligible
Janssen Announces DARZALEX® (daratumumab) U.S. FDA Approval for Newly Diagnosed Patients with Multiple Myeloma who are Transplant Ineligible
HORSHAM, PA, May 9, 2018 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand